Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: risk-factors and prognostic value

Diabetes Research and Clinical Practice
Natalia V ZaytsevaIvan I Dedov

Abstract

To determine risk factors, prognostic, value prevention of development of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) in patients with type 2 diabetes mellitus (T2DM). We have retrospectively analyzed the incidence of CIN developed after PCI in 151 patients T2DM and 50 patients without diabetes. All patients were subjected to thorough clinical examination (including serum creatinine level before and 48 hours after intervention). CIN developed more frequently after PCI in patients with T2DM than in patients of the same age without diabetes at the same baseline renal function, volume of contrast media and hydration status. The risk of developing CIN in patients with T2DM is associated with: heart failure, anemia, volume of contrast media, diuretics use in the peri-procedure period, multiple coronary artery disease, need of interventional procedures. TIDM patients with CIN had faster decline of renal function, more often developed cardiovascular diseases and had lower 24 month survival rate. High risk of CIN development and its prognostic significance in patients with T2DM determine the necessity of individually evaluated risks for preventive measures during contrast media interventions.

References

May 27, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C M Erley
Apr 30, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kevin NashSusan Hou
Jun 15, 2004·The American Journal of Cardiology·Beth A BartholomewWilliam W O'Neill
Nov 18, 2004·AJR. American Journal of Roentgenology·Tadhg G Gleeson, Sudi Bulugahapitiya
Jan 28, 2005·Kidney International·Eugenia NikolskyGeorge Dangas
Feb 12, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Samuel N HeymanSeymour Rosen
May 25, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Ilan Goldenberg, Shlomi Matetzky
Jan 18, 2006·Orvosi hetilap·István PintérJudit Nagy
Feb 1, 2006·Cleveland Clinic Journal of Medicine·Michael R RudnickStanley Goldfarb
Apr 14, 2006·Kidney International. Supplement·R Mehran, E Nikolsky
May 11, 2006·Nephron. Clinical Practice·Mustafa CiritErtap Esi
May 19, 2006·Kidney & Blood Pressure Research·Omer Toprak, Mustafa Cirit
Jun 22, 2006·JAMA : the Journal of the American Medical Association·Neesh PannuUNKNOWN Alberta Kidney Disease Network

❮ Previous
Next ❯

Citations

Aug 13, 2013·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Benjamin DvoršakRadovan Hojs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.